Articles from BIOTECH Patent News (October 1, 2004)

Title	Author	Type	Words
ActiveHealth Management receives patent for care management technology.			462
Benitec grants ddRNAi license to Artemis for development of transgenics.			529
BioCrystal and Crystalplex in broad cross-licensing fluorescent nanocrystals pact.			481
Biotech patent attorneys join Cooley Godward.			647
Boehringer Ingelheim obtains United States patent.		Brief Article	126
Boehringer Ingelheim obtains United States patent.		Brief Article	95
Boehringer Ingelheim obtains United States patent.		Brief Article	112
Boehringer Ingelheim obtains United States patent.		Brief Article	96
Boehringer Ingelheim obtains United States patent.		Brief Article	79
Boehringer Ingelheim obtains United States patent.		Brief Article	103
Boehringer Ingelheim obtains United States patent.		Brief Article	81
Boehringer Ingelheim obtains United States patent.		Brief Article	108
Boehringer Ingelheim obtains United States patent.		Brief Article	61
Boehringer Ingelheim obtains United States patent.		Brief Article	131
Boehringer Ingelheim obtains United States patent.		Brief Article	92
Boehringer Ingelheim obtains United States patent.		Brief Article	125
Boehringer Ingelheim obtains United States patent.		Brief Article	55
Boehringer Ingelheim obtains United States patent.		Brief Article	92
Bristol-Myers Squibb Medical Imaging and IMCOR Pharmaceutical enter into cross-licensing agreement for ultrasound contrast patents.			320
Competitive Technologies announces patent for nanotechnology bone biomaterial issued.			424
Corcept resolves psychotic patent inventorship dispute.		Brief Article	252
Cord Blood Registry wins cryopreservation patent dispute with PharmaStem.			582
EntreMed and Affymax form tissue factor pathway inhibitor peptides collaboration.			609
Guide published for successful pharmaceutical patent writing.			447
Hana Biosciences licenses rights to lingual spray from NovaDel Pharma for chemotherapy-induced nausea and vomiting.			511
Icoria expands fungicide patent portfolio.			407
InterMune extends hepatitis C drug discovery program with Array BioPharma.			765
Novartis, the Broad Institute of MIT and Harvard form collaboration to uncover genetic basis for type 2 diabetes.			989
Nuvelo gains worldwide rights to Alfimeprase through Amgen licensing agreement.			1091
Oncolytics Biotech announces issuance of cancer patent.		Brief Article	174
Transkaryotic prevails over Kirin-Amgen in House of Lords Dynepo litigation.			394
University of Hawaii licenses Diversa patent for DNA sequence-based discovery from environmental sources.			681
WuXi Pharma recognized for excellence in patent filings.		Brief Article	260